ACT (80)

Report your review integrity concerns. Report your concerns about unfair review. Learn more about integrity & fairness in review.

Special Emphasis Panel for Drug Discovery and Molecular Pharmacology – ACT (80)

Image
TBD

Scientific Review Officer

Applications focused on early stages of discovery and development of novel anti-cancer agents including small molecule inhibitors, natural products, peptides, proteins, peptidomimetics, and immunomodulators.

Review Dates

Topics

  • Initial discovery methods including High-throughput (HTS) assay development, primary screen implementation.
  • Molecular characterization of new anti-cancer agents, including mechanism of action, structural characterization of enzyme-inhibitor complexes, and confirmation of target engagement.
  • Medicinal chemistry focused on lead selection for cancer therapy.
  • Development of mathematical and computational methods for the investigation of therapeutic strategies.

Discover Other Possible Study Sections

Return to Top